The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Today many drug companies which have produced drugs with which the public is very familiar, like Plavix®, Lipitor® and Abilify®
The global Patent Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Patent Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Patent Medicine.
Report Scope
The Patent Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Patent Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Patent Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Pfizer Inc.
- Otsuka Pharmaceutical
- Merck
- Novartis
- Sanofi-Aventis
- Bristol-Myers Squibb Co.
- GSK
Segment by Type
- Product Patents
- Process Patents
Segment by Application
- Adult
- Children
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Patent Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patent Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Product Patents
1.2.3 Process Patents
1.3 Market by Application
1.3.1 Global Patent Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patent Medicine Market Perspective (2019-2030)
2.2 Patent Medicine Growth Trends by Region
2.2.1 Global Patent Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Patent Medicine Historic Market Size by Region (2019-2024)
2.2.3 Patent Medicine Forecasted Market Size by Region (2025-2030)
2.3 Patent Medicine Market Dynamics
2.3.1 Patent Medicine Industry Trends
2.3.2 Patent Medicine Market Drivers
2.3.3 Patent Medicine Market Challenges
2.3.4 Patent Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patent Medicine Players by Revenue
3.1.1 Global Top Patent Medicine Players by Revenue (2019-2024)
3.1.2 Global Patent Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patent Medicine Revenue
3.4 Global Patent Medicine Market Concentration Ratio
3.4.1 Global Patent Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patent Medicine Revenue in 2023
3.5 Patent Medicine Key Players Head office and Area Served
3.6 Key Players Patent Medicine Product Solution and Service
3.7 Date of Enter into Patent Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patent Medicine Breakdown Data by Type
4.1 Global Patent Medicine Historic Market Size by Type (2019-2024)
4.2 Global Patent Medicine Forecasted Market Size by Type (2025-2030)
5 Patent Medicine Breakdown Data by Application
5.1 Global Patent Medicine Historic Market Size by Application (2019-2024)
5.2 Global Patent Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Patent Medicine Market Size (2019-2030)
6.2 North America Patent Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Patent Medicine Market Size by Country (2019-2024)
6.4 North America Patent Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patent Medicine Market Size (2019-2030)
7.2 Europe Patent Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Patent Medicine Market Size by Country (2019-2024)
7.4 Europe Patent Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patent Medicine Market Size (2019-2030)
8.2 Asia-Pacific Patent Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Patent Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Patent Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Patent Medicine Market Size (2019-2030)
9.2 Latin America Patent Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Patent Medicine Market Size by Country (2019-2024)
9.4 Latin America Patent Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patent Medicine Market Size (2019-2030)
10.2 Middle East & Africa Patent Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Patent Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Patent Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Patent Medicine Introduction
11.1.4 Pfizer Inc. Revenue in Patent Medicine Business (2019-2024)
11.1.5 Pfizer Inc. Recent Development
11.2 Otsuka Pharmaceutical
11.2.1 Otsuka Pharmaceutical Company Detail
11.2.2 Otsuka Pharmaceutical Business Overview
11.2.3 Otsuka Pharmaceutical Patent Medicine Introduction
11.2.4 Otsuka Pharmaceutical Revenue in Patent Medicine Business (2019-2024)
11.2.5 Otsuka Pharmaceutical Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Patent Medicine Introduction
11.3.4 Merck Revenue in Patent Medicine Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Patent Medicine Introduction
11.4.4 Novartis Revenue in Patent Medicine Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Detail
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Patent Medicine Introduction
11.5.4 Sanofi-Aventis Revenue in Patent Medicine Business (2019-2024)
11.5.5 Sanofi-Aventis Recent Development
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Company Detail
11.6.2 Bristol-Myers Squibb Co. Business Overview
11.6.3 Bristol-Myers Squibb Co. Patent Medicine Introduction
11.6.4 Bristol-Myers Squibb Co. Revenue in Patent Medicine Business (2019-2024)
11.6.5 Bristol-Myers Squibb Co. Recent Development
11.7 GSK
11.7.1 GSK Company Detail
11.7.2 GSK Business Overview
11.7.3 GSK Patent Medicine Introduction
11.7.4 GSK Revenue in Patent Medicine Business (2019-2024)
11.7.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
